ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesE09.3559

E09.3559

Billable

Drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy (unspecified eye)

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 E09.3559 is a billable code used to indicate a diagnosis of drug or chemical induced diabetes mellitus with stable proliferative diabetic retinopathy (unspecified eye).

Key Diagnostic Point:

E09.3559 refers to diabetes mellitus that has been induced by drugs or chemicals, leading to complications such as stable proliferative diabetic retinopathy in an unspecified eye. This condition arises when certain medications, such as glucocorticoids or antipsychotics, disrupt normal glucose metabolism, resulting in hyperglycemia and subsequent diabetes. Proliferative diabetic retinopathy is a severe complication characterized by the growth of new blood vessels in the retina, which can lead to vision loss. The term 'stable' indicates that the retinopathy has not progressed, but ongoing monitoring is essential. Management of this condition typically involves controlling blood glucose levels through lifestyle modifications, oral hypoglycemic agents, or insulin therapy, while also addressing the retinopathy through regular ophthalmologic evaluations and potential interventions such as laser therapy. The complexity of managing drug-induced diabetes lies in the need to balance the treatment of the underlying condition necessitating the drug with the management of diabetes and its complications.

Code Complexity Analysis

Complexity Rating: High

High Complexity

Complexity Factors

  • Identification of the specific drug or chemical causing diabetes.
  • Differentiation between drug-induced diabetes and other types of diabetes.
  • Assessment of the severity and stability of diabetic retinopathy.
  • Management of multiple comorbidities related to diabetes.

Audit Risk Factors

  • Inadequate documentation of the drug or chemical causing diabetes.
  • Failure to document the stability of diabetic retinopathy.
  • Incorrect coding of the type of diabetes.
  • Lack of follow-up documentation on HbA1c levels.

Specialty Focus

Medical Specialties

Endocrinology

Documentation Requirements

Detailed medication history, HbA1c levels, and treatment plans.

Common Clinical Scenarios

Patients presenting with new-onset diabetes after starting a new medication.

Billing Considerations

Close monitoring of blood glucose levels and potential adjustments in diabetes management.

Ophthalmology

Documentation Requirements

Detailed retinal examination findings and treatment plans for retinopathy.

Common Clinical Scenarios

Patients with diabetes presenting for routine eye exams or treatment of retinopathy.

Billing Considerations

Documentation of the stability of retinopathy and any interventions performed.

Coding Guidelines

Inclusion Criteria

Use E09.3559 When
  • According to ICD
  • 10 guidelines, E09
  • 3559 should be used when diabetes is specifically induced by drugs or chemicals, and there is evidence of stable proliferative diabetic retinopathy
  • Coders must ensure that the medical record supports the diagnosis and that the retinopathy is documented as stable

Exclusion Criteria

Do NOT use E09.3559 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

99213CPT Code

Established patient office visit, Level 3

Clinical Scenario

Used for follow-up visits for diabetes management.

Documentation Requirements

Document the patient's diabetes management plan and any changes in medication.

Specialty Considerations

Endocrinologists should ensure comprehensive documentation of diabetes control.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of drug-induced diabetes, improving the accuracy of diabetes-related data collection and management. This specificity aids in better patient care and resource allocation.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of drug-induced diabetes, improving the accuracy of diabetes-related data collection and management. This specificity aids in better patient care and resource allocation.

Reimbursement & Billing Impact

reimbursement.

Resources

Clinical References

  • •
    American Diabetes Association

Coding & Billing References

  • •
    American Diabetes Association

Frequently Asked Questions

What medications can induce diabetes?

Medications such as glucocorticoids, certain antipsychotics, and some antihypertensives can induce diabetes by affecting insulin sensitivity or secretion.